Avalyn Pharma
$25.63
1
-$0.08-0.31%Friday 20:00
-$0.45-1.76%Friday 20:34After hours
Statistics
Day High
25.7
Day Low
25.54
52W High
40.17
52W Low
22.24
Volume
9,590
Avg. Volume
-
Mkt Cap
1.14B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Dec 2Expected
Q2 2026
Next
-0.98
-0.89
-0.8
-0.71
Expected EPS
-0.713333
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-85.2MNet Income
Analyst Ratings
$62.00Average Price Target
The highest estimate is 80.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.
Show More
CEO
Lyn Baranowski
Employees
55
Country
United States
ISIN
US05348Y1055
Listings
0 Comments
Share your thoughts
FAQs
What is Avalyn Pharma stock price today?▼
The current price of AVLN is $25.63 USD — it has decreased by -0.31% in the past 24 hours. Watch Avalyn Pharma stock price performance more closely on the chart.
What is Avalyn Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Avalyn Pharma stocks are traded under the ticker AVLN.
What is Avalyn Pharma market cap?▼
Today Avalyn Pharma has the market capitalization of 1.14B
When is the next Avalyn Pharma earnings date?▼
Avalyn Pharma is going to release the next earnings report on December 2, 2026.
What were Avalyn Pharma earnings last quarter?▼
AVLN earnings for the last quarter are -0.98 USD per share, whereas the estimation was -0.76 USD resulting in a -29.52% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Avalyn Pharma revenue for the last year?▼
Avalyn Pharma revenue for the last year amounts to 0 USD.
What is Avalyn Pharma net income for the last year?▼
AVLN net income for the last year is -85.2M USD.
How many employees does Avalyn Pharma have?▼
As of November 1, 2026, the company has 55 employees.
In which sector is Avalyn Pharma located?▼
Avalyn Pharma operates in the Health & Wellness sector.
When did Avalyn Pharma complete a stock split?▼
The last stock split for Avalyn Pharma was on September 25, 2007 with a ratio of 1:3.
Where is Avalyn Pharma headquartered?▼
Avalyn Pharma is headquartered in BOSTON, United States.